Search results
Results from the WOW.Com Content Network
Antiarrhythmic agents, also known as cardiac dysrhythmia medications, are a class of drugs that are used to suppress abnormally fast rhythms (tachycardias), such as atrial fibrillation, supraventricular tachycardia and ventricular tachycardia. Many attempts have been made to classify antiarrhythmic agents.
1 Antiarrhythmic agents. 2 ACE inhibitors. 3 Alpha blockers. 4 Angiotensin II receptor antagonists. 5 Beta blocker. 6 Mixed alpha + beta blockers. 7 Calcium channel ...
R. RAF Centre of Aviation Medicine; Remedy UK; Royal British Nurses' Association; Royal College of Anaesthetists; Royal College of Emergency Medicine; Royal College of General Practitioners
The Association of British HealthTech Industries, formerly the Association of British Healthcare Industries is a trade association for the medical technology sector in the UK. It has about 250 member companies which together provide 80% of the medical technology used in the NHS. It has offices in London.
Bretylium (also bretylium tosylate) is an antiarrhythmic agent. [1] It blocks the release of noradrenaline from nerve terminals. In effect, it decreases output from the peripheral sympathetic nervous system. It also acts by blocking K + channels and is considered a class III antiarrhythmic.
The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices. There are currently eight such committees: [citation needed] Advisory Board on the Registration of Homeopathic Products; Herbal Medicines Advisory Committee; The Review Panel
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B. [1] Co-founded by Joseph J. Krivulka. It was known for six major products, including Lovaza (Omega-3), Axid (H2 blocker), Dynacirc CR (calcium channel blocker), Antara (fenofibrate), InnoPran XL (beta blocker), Lescol XL (Fluvastatin), and Rythmol SR (Class IC anti-arrhythmic).
Disopyramide (INN, trade names Norpace and Rythmodan) is an antiarrhythmic medication used in the treatment of ventricular tachycardia. [2] It is a sodium channel blocker and is classified as a Class 1a anti-arrhythmic agent. [3] [4] Disopyramide has a negative inotropic effect on the ventricular myocardium, significantly decreasing the ...